THERANOSTIC FOR P4 MEDICINE

The transition from today population-based "reactive" medicine to the individual patient-centred data-driven medicine of tomorrow is the big challenge that the health system will face in the next years worldwide. Therefore, in addition to the clinical-pathological parameters, many other factors such as inherited genetics, ethnicity, age and gender, lifestyle including nutrition and, more generally, the socio-economic environment will have to be taken into consideration. Within this frame, the main aim was to collect opinions from international experts in order to identify long term future needs and bottlenecks in the exploitation of Theranostics for a Predictive, Preventive, Personalized and Participatory Medicine (P4-Medicine).